The Chillicothe Voice | Press Releases

Black Rock Coffee Bar

Black Rock Coffee Bar CEO Mark Davis named 2026 EY Entrepreneur Of The Year® Pacific Southwest finalist

Under Davis’ leadership, Black Rock Coffee Bar has delivered strong performance and completed its initial public offering

Kite

AI Website Builder Kite Turns Any LinkedIn Profile Into a Personal Website in One Click

Nutromics Secures AU$3 Million in CRC Projects Funding to Develop World-First Sepsis Management Patch

Building on landmark Nature Biotechnology findings, Nutromics secures AU$3 million in a AU$11.2 million consortium to develop a world-first wearable sepsis patch.
MELBOURNE, Australia, April 27, 2026 (EZ Newswire) -- Nutromics, an Australian founded startup developing a wearable molecular sensing platform, today announced it has secured AU$3 million in non-dilutive funding through the Australian Government's Cooperative Research Centres (CRC) Projects Round 18, as part of a total project value of AU$11.2 million. The funding will support the development of a world-first sepsis management microneedle patch capable of real-time, multi-analyte sensing with sensor design accelerated by cutting-edge robotics.
Sepsis is the leading cause of death globally, with 11 million sepsis-related deaths in 2020, according to the World Health Organization (WHO). A national analysis from the Australian Commission on Safety and Quality in Health Care found that it affects around 84,000 people each year in Australia alone, of which 12,000 will die. Every hour of delayed treatment increases sepsis mortality risk by 8%, despite advances in modern medicine.
Running from July 1, 2026 to June 30, 2029, this project brings together a consortium of industry and academic partners including Bosch Australia Manufacturing Solutions (BAMS), Global Life Sciences Solutions Australia Pty Ltd T/as Cytiva, The University of Sydney, The University of New South Wales, Tecan Australia, and A.T.A Scientific. The consortium will develop a wearable patch that gives clinicians the ability to identify and monitor sepsis in real time, enabling earlier intervention and saving lives. The patch will be validated in a clinical study across ICU and emergency settings, building Australia's sovereign diagnostic capability.
This announcement represents further significant progress for Nutromics, following the landmark publication of its first-in-human studies earlier this year in Nature Biotechnology, which demonstrated for the first time that a wearable molecular sensing platform can continuously measure drug levels in real time in the human body.
"Sepsis kills with speed, and today our tools simply aren't fast enough to match it. That is exactly why this is a problem we are focusing our efforts on," said Hitesh Mehta, COO and Co-founder of Nutromics. "This CRC Projects grant validates both the urgency of the clinical need and the strength of our platform to address it. By combining Nutromics' DNA-based sensing technology with robotics-accelerated sensor design and a world-class consortium, we have a genuine opportunity to transform how sepsis is managed in hospitals across Australia and beyond."
"Sepsis remains one of medicine's most pressing and deadly challenges. Nutromics has already shown their platform works in humans," said Prof. Justin Gooding from the University of New South Wales. "We are building on a proven foundation and directing it at one of the highest-value clinical targets imaginable. The potential to save lives is real."
The Nutromics sepsis patch will leverage the same core molecular sensing platform, adapted for multi-analyte detection of key sepsis biomarkers. The technology's capabilities in humans were recently demonstrated and published in Nature Biotechnology, and multi-analyte capability was presented at the International Congress of Therapeutic Drug Monitoring and Clinical Toxicology (IATDMCT) last year.
Robotics will be deployed to accelerate sensor design and optimisation, compressing development timelines and enhancing sensing precision. Clinical validation across ICU and emergency settings is designed to meet the demands of real-world deployment and lay the groundwork for regulatory pathways and future commercialisation.
About Nutromics
Nutromics is an Australian-founded advanced monitoring company that has built a wearable, DNA-based platform for continuous molecular monitoring. Its electrochemical aptamer-based sensors, integrated with minimally invasive microneedles, are designed to sense multiple proteins, drugs, metabolites, and hormones in real time. Nutromics is advancing toward regulatory clearance and commercial launch of its first product, with operations in Australia and the United States. The company’s vision is a world with zero preventable deaths due to a lack of continuous molecular monitoring. For more information, visit www.nutromics.com.
Media Contact
Royina Bakshi Lock
 Nutromics
 roy.bakshi@nutromics.com
### 

 SOURCE: Nutromics

A&amp;A Sports Group LLC

A&amp;A Sports Group LLC Revolutionizes Athlete Support with Insurance and Retirement Accounts

Founder Alander Pulliam Advocates for Comprehensive Athlete Care

GigSafe

GigSafe Integrates with CXT to Advance Intelligent, Data-Driven Last Mile Contractor Compliance

SuperTruth, Inc.

Health AI Has Been Trained on Unscored Data. SuperTruth Just Published the Standard That Fixes It.

Hexagon

Distribution and listing of Octave Intelligence plc

Glancy Prongay Wolke &amp; Rotter LLP

Deadline Alert: Coty Inc. (COTY) Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke &amp; Rotter LLP About Securities Fraud Lawsuit

BTC ECOSYSTEM

As the CLARITY Act Deadline Approaches, btcecosystem Focuses on a Pivotal Turning Point in Crypto Regulation.

Against the backdrop of an increasingly maturing global digital asset market, the U.S. *Clarity for Digital Assets Act* is entering a critical phase of the legislative process.

Global Virus Network

Global Virus Network Statement on H5N1 Vaccine Developments

New vaccine momentum reflects growing urgency of avian influenza (H5N1) threat and reinforces need for coordinated global preparedness, building on prior analysis published in The Lancet Regional Health—Americas

Global Sources

Global Sources Sports &amp; Outdoor Officially Opens

Berger Montague

SHAREHOLDER ALERT: Berger Montague Reminds Concorde International Group, Ltd. (NASDAQ: CIGL) Investors of Class Action Lawsuit Deadline

JumpCloud, Inc.

JumpCloud Launches Agentic IAM to Govern the AI Lifecycle

Cultural Council For Palm Beach County

MOSAIC Returns This May with Record-Breaking Number of Deals Now Live Across The Palm Beaches

36 offers from 32 cultural organizations make arts and culture more accessible than ever, with savings on admission, performances, and experiences throughout Palm Beach County

Shell plc

Transaction in Own Shares

AxiomPrint, Inc.

AxiomPrint Introduces Automated Print Platform Designed to Transform Custom Projects into Scalable Workflows

Kean University

Middle States Commission on Higher Education Advances Historic Merger of Kean University and New Jersey City University

Boosalis Properties

Boosalis Properties Named Among CoStar's Top Retail Brokers in Washington, D.C. Market

Concierra Legal

Concierra Legal Introduces Strategic Contract Architecture Approach to Address AI-Driven Legal Risks for Businesses

Having a Strategic Legal Architect Review Agreements Before They Are Signed Can Help Founders and Entrepreneurs Get Ahead of the Litigation Risks Hidden in Poorly Designed Contracts

Amesite Inc.

Amesite Announces Up To $6 Million Concurrent Registered Direct Offering and Private Placement Priced At-the-Market Under Nasdaq Rules

$2 million upfront with up to approximately $4 million of potential aggregate proceeds upon the exercise in full of warrants